作者
Gabriele Togliatto, Antonella Trombetta, Patrizia Dentelli, Alessandra Baragli, Arturo Rosso, Riccarda Granata, Dario Ghigo, Luigi Pegoraro, Ezio Ghigo, Maria Felice Brizzi
发表日期
2010/4/1
期刊
Diabetes
卷号
59
期号
4
页码范围
1016-1025
出版商
American Diabetes Association
简介
OBJECTIVE
Acylated ghrelin (AG) is a diabetogenic and orexigenic gastric polypeptide. These properties are not shared by the most abundant circulating form, which is unacylated (UAG). An altered UAG/AG profile together with an impairment of circulating endothelial progenitor cell (EPC) bioavailability were found in diabetes. Based on previous evidence for the beneficial cardiovascular effects of AG and UAG, we investigated their potential to revert diabetes-associated defects.
RESEARCH DESIGN AND METHODS
Healthy human subjects, individuals with type 2 diabetes, and ob/ob mice were AG or UAG infused. EPC mobilization in patients and mice was evaluated, and the underlying molecular mechanisms were investigated in bone marrow stromal cells. Recovered EPCs were also evaluated for the activity of senescence regulatory pathways and for NADPH oxidase …
引用总数
201020112012201320142015201620172018201920202021202220238101611167994441
学术搜索中的文章